These results collectively highlight the role of SF3B1 mutation in driving downstream clonal changes, including novel CNV events such as LOY, and suggesting that LOY is a conserved mutant SF3B1 phenotype in CLL. This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.